Eli Lilly's Mounjaro receives UK MHRA approval for weight loss

1. 1Eli Lilly's (LLY) once-daily weight-loss pill Mounjaro (orforglipron) has been approved in the UK
2. 2The UK MHRA authorized it for weight loss and maintenance in adults with obesity and for blood-sugar control in type 2 diabetes, making it the first GLP-1 tablet in Europe
3. 3It is not yet available through the NHS weight-management program, and Lilly plans to seek a recommendation from NICE, according to BBC

Source Stocktwits +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →